Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page
- Check13 days agoChange DetectedRemoved the 'Prostate cancer' tag and the 'MedlinePlus Genetics' related topics from the page. This changes how the study is categorized and surfaced in topic-based navigation and related links.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page received new user-help and navigation sections, including How to Read a Study Record, Common Questions, How to Join a Study, and related topic links. The Interventions label was standardized from 'Intervention / Treatment' to 'Intervention/Treatment' and a new site revision tag (Revision: v3.6.0) was added.SummaryDifference0.6%

- Check28 days agoChange DetectedThe page now shows a new revision label: Revision: v3.5.5. The previous revision label Revision: v3.5.4 has been removed, reflecting an updated version of the page metadata.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded Revision: v3.5.4 to the page, indicating a version update. Removed the related topics entries for Prostate cancer and MedlinePlus Genetics, and the 'related topics' label from the page's related topics section.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now includes related topics: Prostate cancer and MedlinePlus Genetics. These additions provide quick access to background information and genetics resources relevant to the study.SummaryDifference0.2%

- Check63 days agoChange DetectedThe related topics area was trimmed by removing the 'Prostate cancer' label and the 'MedlinePlus Genetics' item, reducing navigational references without changing the study information.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.